Cyrille Tupin

About Cyrille Tupin

Cyrille Tupin is a French executive with a background in audit, accounting, and corporate governance, best known for serving as Chief Executive Officer of ABIONYX Pharma. In this role, he has been central to the company’s strategic and operational leadership, at the intersection of biotech development, listed-company governance, financing, and investor-facing communication. ABIONYX presents him as a senior manager whose responsibilities support the execution of the group’s strategy in innovative therapies for renal and ophthalmological diseases. Before joining ABIONYX Pharma, Tupin was Audit Director at Sygnatures, a private audit and consulting firm in Toulouse. He also spent more than seven years at PricewaterhouseCoopers, including two years of international experience in Canada. His career includes work on major, high-profile transactions, notably Alcan’s takeover bid for Pechiney and the consolidation audit of Pechiney for Alcan. This indicates significant expertise in complex transactions, statutory audit, and group financial reporting. ABIONYX also states that he has been a French CPA since 2002, and that his professional thesis focused on the financial statement impact of restructuring costs, which reinforces his technical profile in accounting and financial analysis. His profile is particularly relevant for a publicly listed biotech company, where strong financial discipline, governance rigor, and clear reporting are essential. At ABIONYX Pharma, Tupin has helped provide leadership continuity and financial credibility as the company advances its development programs and capital markets strategy. His combination of audit experience, international exposure, and familiarity with large-scale corporate transactions makes him well suited to oversee the demands of a listed life sciences business that must balance innovation, regulation, and long-term value creation.